The Ecological Footprint of COVID-19 mRNA Vaccines: Estimating Greenhouse Gas Emissions in Germany

被引:21
|
作者
Kurzweil, Peter [1 ]
Mueller, Alfred [2 ]
Wahler, Steffen [3 ]
机构
[1] Tech Univ Appl Sci OTH, Dept MBUT, Kaiser Wilhelm Ring 23, D-92224 Amberg, Germany
[2] Analyt Serv, Jahnstr 34c, D-80469 Munich, Germany
[3] St Bernward GmbH, Friedrich Kirsten Str 40, D-22391 Hamburg, Germany
关键词
ecological impact analysis; CO2; footprint; COVID-19; vaccine; CARBON FOOTPRINT; ENVIRONMENT; ENERGY;
D O I
10.3390/ijerph18147425
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Compared to the medical, economic and social implications of COVID-19 vaccinations, little attention has been paid to the ecological balance to date. This study is an attempt to estimate the environmental impact of two mRNA vaccines in terms of CO2 equivalents with respect to their different freezing strategies and supply chain organization. Although it is impossible to accurately calculate the actual environmental impact of the new biochemical synthesis technology, it becomes apparent that transport accounts for up to 99% of the total carbon footprint. The emissions for air freight, road transportation and last-mile delivery are nearly as 19 times the emissions generated from ultra-deep freeze technologies, the production of dry ice, glass and medical polymers for packaging. The carbon footprint of a single mRNA vaccine dose injected into a patient is about 0.01 to 0.2 kg CO2 equivalents, depending on the cooling technology and the logistic routes to the vaccination sites in Germany.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Green Recovery Policies for the COVID-19 Crisis: Modelling the Impact on the Economy and Greenhouse Gas Emissions
    Lahcen, B.
    Brusselaers, J.
    Vrancken, K.
    Dams, Y.
    Paes, C. Da Silva
    Eyckmans, J.
    Rousseau, S.
    ENVIRONMENTAL & RESOURCE ECONOMICS, 2020, 76 (04) : 731 - 750
  • [32] Green Recovery Policies for the COVID-19 Crisis: Modelling the Impact on the Economy and Greenhouse Gas Emissions
    B. Lahcen
    J. Brusselaers
    K. Vrancken
    Y. Dams
    C. Da Silva Paes
    J. Eyckmans
    S. Rousseau
    Environmental and Resource Economics, 2020, 76 : 731 - 750
  • [33] Research and Nonresearch Industry Payments for COVID-19 mRNA Vaccines in the United States
    Murayama, Anju
    Kamamoto, Sae
    Saito, Hiroaki
    Tanimoto, Tetsuya
    Ozaki, Akihiko
    JMA JOURNAL, 2023, 6 (02): : 201 - 203
  • [34] Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines
    Vidula, Mahesh K.
    Ambrose, Marietta
    Glassberg, Helene
    Chokshi, Neel
    Chen, Tiffany
    Ferrari, Victor A.
    Han, Yuchi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [35] Immune Thrombocytopenia Relapse in Patients Who Received mRNA COVID-19 Vaccines
    Qasim, Hana
    Rahhal, Alaa
    Husain, Ahmed
    Alammora, Abdelkarim
    Alsa'ed, Khaled
    Alsayed, Ahmed Abdelghafar Masaad
    Faiyoumi, Baha
    AbuAfifeh, Leen Maen
    Abu-Tineh, Mohammad
    Alshurafa, Awni
    Yassin, Mohamed A.
    JOURNAL OF BLOOD MEDICINE, 2023, 14 : 295 - 302
  • [36] Anaphylaxis and COVID-19 vaccines
    Castells, M.
    Demoly, P.
    Tanno, L. K.
    REVUE FRANCAISE D ALLERGOLOGIE, 2021, 61 (08): : S30 - S35
  • [37] Recombinant vaccines for COVID-19
    Yadav, Tushar
    Srivastava, Nishant
    Mishra, Gourav
    Dhama, Kuldeep
    Kumar, Swatantra
    Puri, Bipin
    Saxena, Shailendra K.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (12) : 2905 - 2912
  • [38] Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review
    SeyedAlinaghi, SeyedAhmad
    Karimi, Amirali
    Pashaei, Zahra
    Afzalian, Arian
    Mirzapour, Pegah
    Ghorbanzadeh, Kobra
    Ghasemzadeh, Afsaneh
    Dashti, Mohsen
    Nazarian, Newsha
    Vahedi, Farzin
    Tantuovir, Marcarious M.
    Shamsabadi, Ahmadreza
    Dadras, Omid
    Mehraeen, Esmaeil
    ARCHIVES OF ACADEMIC EMERGENCY MEDICINE, 2022, 10 (01)
  • [39] Making COVID-19 mRNA vaccines accessible: challenges resolved
    Niazi, Sarfaraz K.
    EXPERT REVIEW OF VACCINES, 2022, 21 (09) : 1163 - 1176
  • [40] Role of nanotechnology behind the success of mRNA vaccines for COVID-19
    Khurana, Amit
    Allawadhi, Prince
    Khurana, Isha
    Allwadhi, Sachin
    Weiskirchen, Ralf
    Banothu, Anil Kumar
    Chhabra, Deepak
    Joshi, Kamaldeep
    Bharani, Kala Kumar
    NANO TODAY, 2021, 38